/**/ document.writeln("\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n\n\n\n\n\n\n \n \n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n
QuoteChartsNewsFilingsHistorical
\n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Aeolus Pharmaceuticals Inc. (AOLS) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 0.30\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n 0.00\n\n (0.00%)\n\n \n\n \n\n \n\n \n\n Volume: 0\n\n \n\n \n\n\n\n 12:38 PM EST Nov 20, 2009\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
October 22,2009
\n \n
Close: \n 0.55\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
March 02,2009
\n \n
Close: \n 0.15\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
0.30
\n 		\n\n \n \n \n
Change $
\n \n \n \n
\n 		\n \n\n \n \n
Change %
\n\n \n \n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
0.31
\n 		\n \n \n \n\n
Bid Size
50
\n 		\n \n \n \n
Ask
0.405
\n\n 		\n \n \n \n
Ask Size
50
\n
\n \n \n \n
Open
N/A
\n 		\n \n \n \n
High
N/A
\n 		\n\n \n \n \n
Low
N/A
\n 		\n \n\n \n \n
Prev Close
0.30
\n
\n \n\n \n \n
Last Trade
11/20/09
\n 		\n \n \n \n
Volume
0
\n 		\n \n \n \n
\n
52 Wk Hi
0.55
\n 		\n\n \n \n \n
52 Wk Low
0.15
\n
\n \n\n \n \n
Market Cap
11.24 m
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
37,467,855
\n 		\n \n \n \n
EPS (TTM)
-0.08
\n 		\n \n \n \n\n
PE Ratio
N/A
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
OTC Bulletin Board (OBB)
\n
\n
\n
\n
\n
\n \n
Exchange
OBB
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Aeolus Pharmaceuticals Inc.\n\n \n\n  (AOLS) \n\n \n\n \n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking &\nFinance
\n\n
Capital Gains
\n
Mergers &\nAcquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary\nFund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for AOLS\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Nov 17, 2009
\n\n \n\n\n\n
9:00 AM\n\n\n\n Duke University Initiates Study of AEOL 10150 to Measure Compound's Ability to Protect Healthy Tissue in Mice Receiving Chemotherapy and Radiation for Non-Small Cell Lung Cancer - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Nov 05, 2009
\n\n \n\n\n\n
9:44 AM\n\n\n\n Data Demonstrating Aeolus Pharmaceuticals' AEOL 10150's Efficacy as a Broad Spectrum Countermeasure Against Radiological and Chemical Threats Presented at the GHSI Public Health Emergency Medical Countermeasures Workshop - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Nov 04, 2009
\n\n \n\n\n\n
1:34 PM\n\n\n\n Aeolus Pharmaceuticals' AEOL 10150 Protects Lungs Against Chlorine Gas Exposure in Animal Studies - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Oct 22, 2009
\n\n \n\n\n\n
12:12 PM\n\n\n\n Aeolus Drug Protects the Gastrointestinal Tract in Acute Radiation Syndrome Studies Sponsored by the National Institutes of Health's National Institute for Allergy and Infectious Diseases - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Oct 15, 2009
\n\n \n\n\n\n
11:19 AM\n\n\n\n Animal Data Demonstrating Aeolus Pharmaceuticals' AEOL 10150's Efficacy in Mitigating Radiation Damage to the Lung Presented at the 55th Annual Meeting of the Radiation Research Society - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Oct 07, 2009
\n\n \n\n\n\n
9:00 AM\n\n\n\n Aeolus Pharmaceuticals' AEOL 10150 Protects Lungs Against Mustard Gas Exposure in Animal Studies - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Oct 06, 2009
\n\n \n\n\n\n
4:30 PM\n\n\n\n Aeolus Pharmaceuticals Completes $1.65 Million Financing, Converts $1 Million in Debt to Common Stock and Receives an Option to Raise Additional $1.65 Million - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Sep 14, 2009
\n\n \n\n\n\n
9:00 AM\n\n\n\n Aeolus Pharmaceuticals Initiates Second Study of AEOL 10150 as a Countermeasure to Radiation Exposure in Mice - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Sep 11, 2009
\n\n \n\n\n\n
9:00 AM\n\n\n\n Aeolus Pharmaceuticals Submits White Paper to BARDA for Funding of AEOL 10150 as a Countermeasure to Lung Injury Due to Radiation Exposure - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Sep 08, 2009
\n\n \n\n\n\n
12:00 PM\n\n\n\n Aeolus Pharmaceuticals Initiates Study of AEOL 10150 as a Countermeasure to Radiation Exposure in Non-Human Primates - US Equity News
10:37 AM\n\n\n\n Aeolus Pharmaceuticals Initiates Study of AEOL 10150 as a Countermeasure to Radiation Exposure in Non-Human Primates - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Jul 06, 2009
\n\n \n\n\n\n
11:00 AM\n\n\n\n Aeolus Pharmaceuticals' AEOL 10150 Significantly Increases Survival in Mice Exposed to Radiation when Administered After Exposure - US Equity News
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Aug 21, 2006
\n\n \n\n\n\n
7:00 AM\n\n\n\n Aeolus Pharmaceuticals President Featured in Exclusive Interview With WallSt.net - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Jun 20, 2006
\n\n \n\n\n\n
9:04 AM\n\n\n\n Aeolus Pharmaceuticals Selects AEOL 11207 as First Pipeline Development Candidate - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Jun 06, 2006
\n\n \n\n\n\n
8:45 AM\n\n\n\n Aeolus Pharmaceuticals Completes $5.0 Million Financing From New Institutional Investors - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, May 12, 2006
\n\n \n\n\n\n
9:01 AM\n\n\n\n Aeolus Pharmaceuticals Announces Second Quarter Financial Results - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Mar 13, 2006
\n\n \n\n\n\n
10:40 AM\n\n\n\n Aeolus Pharmaceuticals Receives $350,000 Milestone Payment and Equity Interest From Cardiovascular Company - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Feb 16, 2006
\n\n \n\n\n\n
9:00 AM\n\n\n\n Aeolus Pharmaceuticals Announces First Quarter Financial Results - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 27, 2005
\n\n \n\n\n\n
9:00 AM\n\n\n\n Aeolus Pharmaceuticals Announces Fiscal Year 2005 Financial Results - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Dec 08, 2005
\n\n \n\n\n\n
9:04 AM\n\n\n\n AEOL 10150 Clinical Data in ALS Patients to be Presented at the 16th International Symposium on ALS/MND - PR Newswire
\n\n More News for AOLS >>
\n\n
\n\n
\n\n\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n\n DL+   Realtime BATS,  \n\n EOD   End Of Day,  \n\n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");